Filing Details
- Accession Number:
- 0001209191-16-156413
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-12-22 10:30:10
- Reporting Period:
- 2016-12-21
- Filing Date:
- 2016-12-22
- Accepted Time:
- 2016-12-22 10:30:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197023 | S Joshua Boger | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-12-21 | 6,500 | $36.30 | 274,725 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-12-21 | 4,100 | $73.65 | 270,625 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-12-21 | 1,300 | $74.35 | 269,325 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-12-21 | 800 | $75.61 | 268,525 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-12-21 | 300 | $76.39 | 268,225 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2016-12-21 | 6,500 | $0.00 | 6,500 | $36.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 21,000 | 2017-01-23 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 13,286 | Indirect | 401k |
| Common Stock | 78,200 | Indirect | Common Stock Held In Trust |
Footnotes
- Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
- Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $73.65 (range $73.06 to $74.05).
- Open market sales reported on this line occurred at a weighted average price of $74.35 (range $74.07 to $75.00).
- Open market sales reported on this line occurred at a weighted average price of $75.61 (range $75.12 to $76.03).
- Open market sales reported on this line occurred at a weighted average price of $76.39 (range $76.13 to $76.52).
- Fully vested.
Billionaire Hedge Funds
